Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 12, 2011, Pages 5923-5929

  Stergiopoulou, Theodouli ^a,b   Meletiadis, Joseph ^b,c   Sein, Tin ^d   Papaioannidou, Paraskevi ^a   Walsh, Thomas J ^b,e   Roilides, Emmanuel ^a,b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^d SAIC FREDERICK INC   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CIPROFLOXACIN;

ANTIBIOTIC THERAPY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; ESCHERICHIA COLI; FUNGUS GROWTH; HUMAN; HUMAN CELL; MAXIMUM PLASMA CONCENTRATION; NEUTROPHIL; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CIPROFLOXACIN; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MICROBIAL SENSITIVITY TESTS; NEUTROPHILS;

EID: 81555200520     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00548-11     Document Type: Article

References (26)

1. Afessa, B., and S. G. Peters. 2006. Major complications following hematopoietic stem cell transplantation. Semin. Respir. Crit. Care Med. 27:297-309. (Pubitemid 44061631)
2. Bekersky, I., et al. 2002. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. Antimicrob. Agents Chemother. 46:828-833. (Pubitemid 34157670)
3. Bellocchio, S., et al. 2004. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol. 172:3059-3069. (Pubitemid 38263695)
4. Brakhage, A. A., S. Bruns, A. Thywissen, P. F. Zipfel, and J. Behnsen. 2010. Interaction of phagocytes with filamentous fungi. Curr. Opin. Microbiol. 13:409-415.
5. Dalhoff, A., and I. Shalit. 2003. Immunomodulatory effects of quinolones. Lancet Infect. Dis. 3:359-371. (Pubitemid 36718015)
6. Dotis, J., et al. 2008. Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus. J. Antimicrob. Chemother. 61:810-817. (Pubitemid 351426064)
7. Dotis, J., et al. 2006. Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus. Antimicrob. Agents Chemother. 50:868-873. (Pubitemid 43327788)
8. Garcia, I., A. Pascual, and E. J. Perea. 1992. Effect of several antimicrobial agents on ciprofloxacin uptake by human neutrophils. Eur. J. Clin. Microbiol. Infect. Dis. 11:260-262.
9. Maurer, N., K. F. Wong, M. J. Hope, and P. R. Cullis. 1998. Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a 1H-NMR study. Biochim. Biophys. Acta 1374:9-20. (Pubitemid 28432041)
10. Meletiadis, J., et al. 2001. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 39:3402-3408. (Pubitemid 32830354)
11. Meletiadis, J., et al. 2006. Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation. J. Infect. Dis. 194:1008-1018. (Pubitemid 44454087)
12. Meletiadis, J., P. E. Verweij, D. T. TeDorsthorst, J. F. Meis, and J. W. Mouton. 2005. Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models. Med. Mycol. 43:133-152. (Pubitemid 40439401)
13. Pascoe, J., and N. Steven. 2009. Antibiotics for the prevention of febrile neutropenia. Curr. Opin. Hematol. 16:48-52.
14. Petraitis, V., et al. 2009. Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose-dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Antimicrob. Agents Chemother. 53:2382-2391.
15. Poch, G., P. Dittrich, and S. Holzmann. 1990. Evaluation of combined effects in dose-response studies by statistical comparison with additive and independent interactions. J. Pharmacol. Methods 24:311-325.
16. Sau, K., et al. 2003. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J. Biol. Chem. 278:37561-37568. (Pubitemid 37175278)
17. Segal, B. H. 2009. Aspergillosis. N. Engl. J. Med. 360:1870-1884.
18. Shen, L. L., J. Baranowski, J. Fostel, D. A. Montgomery, and P. A. Lartey. 1992. DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs. Antimicrob. Agents Chemother. 36:2778-2784.
19. Simitsopoulou, M., et al. 2005. Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B. Antimicrob. Agents Chemother. 49:1397-1403. (Pubitemid 40463368)
20. Simitsopoulou, M., E. Roilides, E. Georgiadou, F. Paliogianni, and T. J. Walsh. 2011. Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus. Med. Mycol. 49:176-185.
21. Steinbach, W. J. 2010. Epidemiology of invasive fungal infections in neonates and children. Clin. Microbiol. Infect. 16:1321-1327.
22. Stergiopoulou, T., et al. 2009. Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus. J. Antimicrob. Chemother. 63:343-348.
23. Stergiopoulou, T., et al. 2008. Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus. Antimicrob. Agents Chemother. 52:2196-2204. (Pubitemid 351758559)
24. Sugar, A. M., X.-P. Liu, and R. J. Chen. 1997. Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs. Antimicrob. Agents Chemother. 41:2518-2521. (Pubitemid 27467566)
25. van Zanten, A. R., et al. 2008. Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study. J. Crit. Care 23:422-430.
26. Zaoutis, T. E., et al. 2010. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin. Infect. Dis. 51:e38-e45.